CD81 通过阻断 CD274/PD-L1 的选择性自噬降解驱动放射抵抗性胶质母细胞瘤的免疫逃逸
CD81 drives immune evasion in radioresistant glioblastoma by blocking selective autophagic degradation of CD274/PD-L1.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:LncRNA GHET1 from bone mesenchymal stem cell-derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3.
LncRNA GHET1 from bone mesenchymal stem cell-derived exosomes improves doxorubicin-induced pyroptosis of cardiomyocytes by mediating NLRP3.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
多柔比星(DOX)是治疗血液系统肿瘤和乳腺癌的重要化疗药物。然而,由于其严重的心脏毒性,其临床应用受到限制。细胞焦亡是一种与DOX诱导的心脏毒性相关的程序性细胞死亡形式。骨髓间充质干细胞来源的外泌体(BMSC-Exos)和内皮祖细胞来源的外泌体(EPC-Exos)在心肌中具有保护作用。
本研究发现,BMSC-Exos可通过抑制细胞焦亡改善DOX诱导的心脏毒性,而EPC-Exos则不能。与EPC-Exo相比,过表达lncRNA GHET1的BMSC-Exo更有效地抑制细胞焦亡,从而对抗DOX诱导的心脏毒性。
进一步研究表明,lncRNA GHET1通过结合IGF2 mRNA结合蛋白1(IGF2BP1)有效降低Nod样受体蛋白3(NLRP3)的表达,NLRP3在细胞焦亡中发挥重要作用,而IGF2BP1是NLRP3 mRNA的非催化性转录后增强因子。
总之,BMSC-Exo释放的lncRNA GHET1通过靶向IGF2BP1减少NLRP3的转录后稳定性,从而改善DOX诱导的细胞焦亡。
Doxorubicin (DOX) is an important chemotherapeutic agent for the treatment of hematologic tumors and breast carcinoma.
However, its clinical application is limited owing to severe cardiotoxicity. Pyroptosis is a form of programmed cell death linked to DOX-induced cardiotoxicity. Bone mesenchymal stem cell-derived exosomes (BMSC-Exos) and endothelial progenitor cells-derived exosomes (EPC-Exos) have a protective role in the myocardium.
Here we found that BMSC-Exos could improve DOX-induced cardiotoxicity by inhibiting pyroptosis, but EPC-Exos couldn't. Compared with EPCs-Exo, BMSC-Exo-overexpressing lncRNA GHET1 more effectively suppressed pyroptosis, protecting against DOX-induced cardiotoxicity.
Further studies showed that lncRNA GHET1 effectively decreased the expression of Nod-like receptor protein 3 (NLRP3), which plays a vital role in pyroptosis by binding to IGF2 mRNA-binding protein 1 (IGF2BP1), a non-catalytic posttranscriptional enhancer of NLRP3 mRNA. In summary, lncRNA GHET1 released by BMSC-Exo ameliorated DOX-induced pyroptosis by targeting IGF2BP1 to reduce posttranscriptional stabilization of NLRP3.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。